Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Stevanato Group SpASTVN -0.19%87 Quick Ratio is 1.08 as of Jun. 2026, which is 11% below its 10-year median of 1.21. GuruFocus rates STVN with a GF Score™ of 87/100 and a GF Value™ of $26.04 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 849 Medical Devices & Instruments companies, Stevanato Group SpA ranks worse than 73.62% on this metric.
Stevanato Group SpA (NYSE:STVN) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Stevanato Group SpA Quick Ratio Related Terms
Stevanato Group SpA Quick Ratio Historical Data
* Premium members only.
The historical data trend for Stevanato Group SpA's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Stevanato Group SpA's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Stevanato Group SpA Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SpA's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Stevanato Group SpA's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Stevanato Group SpA's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Stevanato Group SpA (STVN) has a Quick Ratio of 1.08 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Stevanato Group SpA and its competitors. This is 11% below median its historical median of 1.21. Over the past decade, Stevanato Group SpA's Quick Ratio has ranged from 0.73 to 2.21. According to the industry distribution chart, Stevanato Group SpA ranks #625 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 73.6%.
Is Stevanato Group SpA's Quick Ratio too high?
Stevanato Group SpA's current Quick Ratio of 1.08 is 11% below median its 10-year median of 1.21. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 2.21. The Medical Devices & Instruments industry median Quick Ratio is 1.83. Stevanato Group SpA's value of 1.08 is 41% below this industry median. Based on the distribution chart, Stevanato Group SpA ranks #625 out of 849 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Stevanato Group SpA has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stevanato Group SpA's Quick Ratio compare to MMED and TFX?
According to the Medical Devices & Instruments industry distribution chart, Stevanato Group SpA ranks #625 out of 849 companies for Quick Ratio. This places Stevanato Group SpA in the lower half of its industry. The industry median Quick Ratio is 1.83. Stevanato Group SpA's value of 1.08 is 41% below this benchmark. Historically, Stevanato Group SpA's own Quick Ratio has ranged from 0.73 to 2.21 over the past decade. While the company's 10-year median is 1.21 vs. the industry median of 1.83, Stevanato Group SpA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.83, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Stevanato Group SpA's current Quick Ratio of 1.08 is 41% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Stevanato Group SpA and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stevanato Group SpA's current Quick Ratio is 1.08, which is 11% below median its own 10-year median of 1.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stevanato Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Stevanato Group SpA (STVN) is currently considered Modestly Undervalued. The stock's GF Value™ is $26.04, compared to a current price of $20.28 — trading 22.1% below its estimated fair value. The current Quick Ratio is 1.08, which is 11% below median its 10-year median of 1.21 and 41% below the Medical Devices & Instruments industry median of 1.83. Stevanato Group SpA's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Stevanato Group SpA (STVN), the current Quick Ratio is 1.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Stevanato Group SpA (STVN) Overvalued in 2026?
Based on GuruFocus' analysis, Stevanato Group SpA stock appears to be undervalued.
The current stock price of $20.28 is trading 22.1% below its estimated GF Value™ of $26.04.
GuruFocus considers Stevanato Group SpA to be Modestly Undervalued.
Key valuation signals for STVN:
Quick Ratio: 1.08 (11% below median its 10-year median of 1.21)
GF Value™: $26.04 vs. price of $20.28 (22.1% below fair value)
Industry Position: 41% below the Medical Devices & Instruments median (#625 of 849)
No single metric tells the full story. See the STVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
87GF Score
Get the complete analysis for STVN
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STVN has been successfully added to your 
